Catalog excerpts
LIMIT UNCERTAINTY Day o: Pre-Treatment All chronic wound patients must have accurate diagnosis and treatment of underlying disease and risks. There must be thorough preoperative control of inflammation, ulceration, debris and bioburden, and edema (as best as the disease and available treatments permit). Day i: Debridement Prepare wound bed using standard methods to ensure wound is free of debris and necrotic tissue. Regardless of how well the wound has been prepared and how healthy it looks, Integra Bilayer Wound Matrix must not be placed on an existing wound surface. The entire existing wound must be completely excised or surgically debrided to ensure the wound bed and edges contain viable tissue.
Open the catalog to page 1Clinical Sequence of Integra Bilayer Wound Matrix Day 7-14: Cellular Invasion And Capillary Growth Integra Bilayer Wound Matrix is applied to the excised wound bed. Fluids invade the matrix within minutes of application, adhering it to the wound. The IBWM must conform to and contact the wound surface. Tension within the material will shear the matrix from the silicone, so the material must not be stretched. It can be affixed with sutures, staples, or any suitable alternative. Dermal cells begin migrating into the matrix and establish a new vascular network. The scaffold is eventually...
Open the catalog to page 2Clinical Sequence of Integra Bilayer Wound Matrix INTEGRA LIMIT UNCERTAINTY Day 21+: Silicone Removal Day 21-56+: Wound Closure The silicone layer is removed. Epidermal cells migrate from the wound edges to complete wound The collagen template biodegrades and is absorbed into the body. closure. For larger wounds, a thin epidermal autograft may be considered to facilitate wound closure. A thin 0.004 - 0.006 in. (0.1016 - 0.1524 mm) epidermal autograft may be applied over the new remodeled skin.
Open the catalog to page 3Clinical Sequence of Integra Bilayer Wound Matrix INTEGRA LIMIT UNCERTAINTY Day 21-56+: Wound Closure Epidermal coverage over the wound yields a permanant and lasting wound closure
Open the catalog to page 4All Integra LifeSciences catalogs and technical brochures
-
capture high-torque surgical
12 Pages
-
cadence
4 Pages
-
DuraGen® Secure
8 Pages
-
transducer
2 Pages
-
MAYFIELD®
12 Pages
-
SurgiMend® Hernia Brochure
8 Pages
-
MediHoney® Brochure
9 Pages
-
AmnioExcel® OR Sell Sheet
2 Pages
-
PyroCarbon Implants
8 Pages
-
Wrist Solutions
6 Pages
-
Lower Extremity Reconstruction
28 Pages
-
Integra® Lighting Solutions
4 Pages
-
Integra® CUSA® Excel+
1 Pages
-
CUSA® Excel+ System
4 Pages
-
DuraGen® matrix
2 Pages
-
SurgiMend®
6 Pages
-
Integra® Tissue Technologies
8 Pages
-
DIABETIC SKIN ULCER
16 Pages
-
Auragen™ Cortical Electrodes
4 Pages
-
DuraGen XS
2 Pages
-
Suturable DuraGen™
4 Pages
-
DuraGen Plus
4 Pages
-
MAYFIELD® 2
3 Pages
-
Hermetic Plus™
2 Pages
-
AccuDrain™
4 Pages
-
Oral Surgery
107 Pages
-
Catalog - Endodontics
110 Pages
-
Catalog - Cassette
36 Pages
-
Brochure - Liberator
6 Pages
-
Catalog - Precision Dental
28 Pages
-
LICOX
4 Pages
-
Integra® Licox®
2 Pages
-
Integra® Camino® Flex
6 Pages
-
Camino
10 Pages
-
Jarit Sterilization System
11 Pages
-
Pain Management Procedure Trays
26 Pages
-
CUSA Excel+
8 Pages
-
Integra Miltex
663 Pages
-
Integra VATS
28 Pages
-
Cardiovascular
285 Pages
-
Padgett
322 Pages
-
Integra Podiatry
130 Pages
-
Integra Jarit
916 Pages
-
Integra Laparoscopic
90 Pages
-
Extremity-Reconstructive Surgery
87 Pages
-
Integra Ruggles Redmond
242 Pages
-
Stereotaxy
28 Pages
-
CUSA NXT/Selector
8 Pages
-
Neuro Operating Room
177 Pages
-
CUSA EXcel
12 Pages
-
Neuromonitoring
76 Pages